'Completely out of scope': Experts weigh in on proposed US tariffs on generic drugs
ONP Summary
Trump announced a phased tariff plan on imported generic drugs with 0% duties for two years starting August 1, 2026, escalating to 100% by August 2028. Concurrently, he plans tariffs of 10–12.5% on 60+ trading partners to replace an expiring 10% global levy, citing alleged forced labor violations.
Progressive:Protectionist unilateralism — Progressive outlets emphasize Trump's unilateral tariff decisions and their impact on established suppliers like India.
Moderate:Labor-focused tariff shift — Moderate outlets present the tariffs as restructuring trade rules in response to alleged forced labor violations.
Conservative:Domestic production incentive — Conservative outlets highlight the tariffs as strategy to restore pharmaceutical manufacturing within the US.
New Delhi: Experts have hinted that the proposed US decision of tariffs on generic drugs in the pharmaceutical sector is "out of scope" after US President...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요